Jovian Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jovian Yu has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
- Alan Cooper
Yale University School of Medicine, New Haven, CT
19 shared publications - Justin Kline
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
19 shared publications - James Godfrey
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
18 shared publications - Sonali M. Smith
Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL
18 shared publications - Sravya Tumuluru
Department of Medicine, Cornell University, New York, NY
17 shared publications - Girish Venkataraman
University of Chicago
16 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 22 May 2025
- Published by American Society of Hematology in Blood
- Vol. 145 (21) , 2460-2472
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response
Most patients with diffuse large B-cell lymphoma (DLBCL) treated with immunotherapies such as bispecific antibodies (BsAbs) or chimeric antigen receptor (CAR) T cells fail to achieve durable treatment responses, underscoring the need for a deeper understanding of mechanisms that regulate the immune environment and response to treatment. Here, an integrative multiomics approach was applied to multiple large independent data sets to characterize DLBCL immune environments and to define their association with tumor cell–intrinsic genomic alterations and outcomes to CD19-directed CAR T-cell and CD20 × CD3 BsAb therapies. This approach effectively segregated DLBCLs into 4 immune quadrants (IQs) defined by cell-of-origin and immune-related gene set expression scores. These quadrants consisted of activated B cell–like (ABC) hot, ABC cold, germinal center B cell–like (GCB) hot, and GCB cold DLBCLs. Recurrent genomic alterations were enriched in each IQ, suggesting that lymphoma cell-intrinsic alterations contribute significantly to orchestrating unique DLBCL immune environments. For instance, SOCS1 loss-of-function mutations were significantly enriched among GCB hot DLBCLs, identifying a putative subset of inflamed DLBCLs that may be inherently susceptible to immunotherapy. In patients with relapsed/refractory DLBCL, DLBCL-IQ assignment correlated significantly with clinical benefit with a CD20 × CD3 BsAb (N = 74), but not with CD19-directed CAR T cells (Stanford, N = 51; Memorial Sloan Kettering Cancer Center, N = 69). Thus, DLBCL-IQ provides a new framework to conceptualize the DLBCL immune landscape and suggests the endogenous immune environment has a more significant impact on outcomes to BsAb than CAR T-cell treatment.
- 22 May 2025
- Published by American Society of Hematology in Blood
- Vol. 145 (21) , 2460-2472
Top Cited PapersOpen AccessIntegrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response
Most patients with diffuse large B-cell lymphoma (DLBCL) treated with immunotherapies such as bispecific antibodies (BsAbs) or chimeric antigen receptor (CAR) T cells fail to achieve durable treatment responses, underscoring the need for a deeper understanding of mechanisms that regulate the immune environment and response to treatment. Here, an integrative multiomics approach was applied to multiple large independent data sets to characterize DLBCL immune environments and to define their association with tumor cell–intrinsic genomic alterations and outcomes to CD19-directed CAR T-cell and CD20 × CD3 BsAb therapies. This approach effectively segregated DLBCLs into 4 immune quadrants (IQs) defined by cell-of-origin and immune-related gene set expression scores. These quadrants consisted of activated B cell–like (ABC) hot, ABC cold, germinal center B cell–like (GCB) hot, and GCB cold DLBCLs. Recurrent genomic alterations were enriched in each IQ, suggesting that lymphoma cell-intrinsic alterations contribute significantly to orchestrating unique DLBCL immune environments. For instance, SOCS1 loss-of-function mutations were significantly enriched among GCB hot DLBCLs, identifying a putative subset of inflamed DLBCLs that may be inherently susceptible to immunotherapy. In patients with relapsed/refractory DLBCL, DLBCL-IQ assignment correlated significantly with clinical benefit with a CD20 × CD3 BsAb (N = 74), but not with CD19-directed CAR T cells (Stanford, N = 51; Memorial Sloan Kettering Cancer Center, N = 69). Thus, DLBCL-IQ provides a new framework to conceptualize the DLBCL immune landscape and suggests the endogenous immune environment has a more significant impact on outcomes to BsAb than CAR T-cell treatment.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S3 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S3. Single cell profiles of selected genes across T cell clusters from all samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S3. Single cell profiles of selected genes across T cell clusters from all samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S2. Proportions of all clusters in RLT and cHL samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S2. Proportions of all clusters in RLT and cHL samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S2. Proportions of all clusters in RLT and cHL samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S2. Proportions of all clusters in RLT and cHL samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S1. Cell types and states in the cHL environment
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S1. Cell types and states in the cHL environment
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S4 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S4. Distribution of samples across each T-cell cluster
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S4. Distribution of samples across each T-cell cluster
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S3 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S3. Single cell profiles of selected genes across T cell clusters from all samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S3. Single cell profiles of selected genes across T cell clusters from all samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S5 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S5. Proportions and expanded clonotypes in exhausted/effector CD8+ T cells by EBER and HLA-I expression status
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S5. Proportions and expanded clonotypes in exhausted/effector CD8+ T cells by EBER and HLA-I expression status
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S6 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S6. Markers differentiated across T cell clusters via multi-spectral flow cytometry from all samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S6. Markers differentiated across T cell clusters via multi-spectral flow cytometry from all samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Figure S4 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S4. Distribution of samples across each T-cell cluster
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Supplemental Figure S4. Distribution of samples across each T-cell cluster